Skip to content
The Nexus
DossierENTITY

SGLT2 inhibitors

Coverage of SGLT2 inhibitors in the Nexus archive.

Earliest in view: Jun 13 · 19:00 UTCMost recent: Jun 13 · 19:00 UTC
Co-mentioned in this coverage
GLP-1 receptor agoniststopic1diabetic foot complicationstopic1type 2 diabetestopic1MedPage Todayorganization1
Recent coverage
  • HEALTHJun 13 · 19:00 UTCMEDPAGE TODAY
    GLP-1 and SGLT2 Users Face Different Risk for Diabetic Foot Complication

    A large, real-world analysis found that adults with type 2 diabetes using GLP-1 receptor agonists had significantly lower risks of major diabetic foot complications compared to those using SGLT2 inhibitors. The study highlights differing risk profiles between the two medication classes for diabetic foot outcomes.